Screener
Eton Pharmaceuticals, Inc. ETON Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $37.59M+98.6% | $24.27M+40.4% | $21.28M+82.7% | $22.46M+118% | $18.93M+109% | ||
| $12.18M+73.8% | $9.53M+28.4% | $8.18M+58.2% | $14.6M+263% | $7M+103% | ||
| $25.41M+113% | $14.74M+49.4% | $13.1M+102% | $7.86M+24.6% | $11.92M+112% | ||
| 67.6%+4.6pp | 60.7%+3.7pp | 61.6%+6.0pp | 35%-26.1pp | 63%+1.0pp | ||
| $993K-73.2% | $1.88M+61.5% | $1.78M— | $1.11M+120% | $3.71M+25.0% | ||
| $11.63M+20.0% | $10.45M+13.9% | $8.86M+31.8% | $8.11M+53.3% | $9.69M+73.3% | ||
| $12.62M-5.8% | $12.32M+19.3% | $10.64M+81.9% | $9.22M+59.1% | $13.4M+56.5% | ||
| $12.79M+967% | $2.41M+614% | —— | -$1.36M-368% | -$1.48M+49.7% | ||
| 34%+41.8pp | 9.9%+12.7pp | —— | -6.1%-11.0pp | -7.8%+24.6pp | ||
| -$1.08M-3.1% | -$840K+18.3% | —— | -$592K-7,300% | -$1.04M-1,908% | ||
| $11.72M+565% | $1.57M+205% | —— | -$1.96M-490% | -$2.52M+15.7% | ||
| $140K+112% | $20K-73.0% | —— | -$28K+77.8% | $66K+22.2% | ||
| $11.58M+548% | $1.55M+199% | —— | -$1.93M-407% | -$2.59M+15.0% | ||
| 30.8%+44.5pp | 6.4%+15.5pp | —— | -8.6%-14.7pp | -13.7%+19.9pp | ||
| $0.35+450% | $0.05+183% | —— | -$0.07-450% | -$0.10+16.7% | ||
| $14.18M+3,117% | $3.55M+553% | —— | -$354K-145% | -$470K+82.3% | ||
| 37.7%+40.2pp | 14.6%+11.5pp | —— | -1.6%-9.2pp | -2.5%+26.8pp | ||
| $12.79M+967% | $2.41M+614% | —— | -$1.36M-368% | -$1.48M+49.7% |
FAQ
- What is Eton Pharmaceuticals, Inc.'s revenue?
- Eton Pharmaceuticals, Inc. (ETON) generated $105.6M in revenue over the trailing twelve months, up 81.5% year over year.
- Is Eton Pharmaceuticals, Inc. profitable?
- Eton Pharmaceuticals, Inc. reported $8.6M in net income over the trailing twelve months, a -9.5% net margin.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 57.9% and operating margin is -15.1%, with a -9.5% net margin.
- What is Eton Pharmaceuticals, Inc.'s earnings per share?
- Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $0.23.
- Where does Eton Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
